Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1673501000001115 | Indacaterol + Mometasone | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1673521000001110 | Indacaterol + Mometasone (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Indacaterol + Mometasone | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol + Mometasone | Is a | Product containing beta-2 adrenergic receptor agonist | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Indacaterol 125micrograms/dose / Mometasone 127.5micrograms/dose inhalation powder capsules with device | Is a | True | Indacaterol + Mometasone | Inferred relationship | Existential restriction modifier | |
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device | Is a | True | Indacaterol + Mometasone | Inferred relationship | Existential restriction modifier | |
| Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device | Is a | True | Indacaterol + Mometasone | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR